Administrative Core
行政核心
基本信息
- 批准号:10017666
- 负责人:
- 金额:$ 31.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-20 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAdvisory CommitteesAwardBig DataBioinformaticsBudgetsChildhoodClinicalClinical InvestigatorClinical ResearchClinical and Translational Science AwardsCommunicationCommunitiesComparative Effectiveness ResearchDataDiseaseDistance LearningEnsureFacultyGoalsGrantHospitalsIndividualInflammatoryInformation DisseminationInternationalLeadershipLibrariesMentorsMethodologyMethodsMissionMusculoskeletalNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNatural Language ProcessingOnline SystemsPediatric ResearchPersonnel ManagementPhenotypePhysical MedicinePhysical RehabilitationProtocols documentationRecoveryResearchResearch PersonnelResearch TrainingResourcesRheumatologyRunningSamplingScienceServicesStructureSumSupervisionSurveysTrainingTraining ProgramsTreatment outcomeUnited States National Institutes of HealthWomanWorkadvanced analyticsbasebehavioral economicsbioinformatics resourceclinical centercostdesignexperiencefallsfollow-upimprovedinnovationmHealthmedical schoolsmeetingsnext generationprogramsservice coordinationsocial mediaweb sitewebinar
项目摘要
ABSTRACT
The Administrative Core represents the executive, training, coordinating and oversight component of the
Brigham and Women’s Hospital (BWH) Core Centers for Clinical Research (CCCR). The BWH CCCR,
VERITY (Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics), taps into the
resources of the BWH and Harvard Medical School (HMS) affiliated hospitals to offer services to the
community of clinical investigators defined by the NIAMS mission, locally and nationally. The services provided
by the Methods and Bioinformatics Resource Cores respond to needs we have identified for better access to a
complete array of trial and bioinformatics methods organized in a streamlined and readily accessible format.
The Administrative Core contains an innovative Enrichment Program to train and mentor pediatric and adult
rheumatic and musculoskeletal (MSK) clinical researchers, both locally and nationally. The Enrichment
Program builds on preliminary national survey data of pediatric and adult training program directors
characterizing the need for clinical research training and ongoing research mentoring. The overall purpose of
the VERITY Administrative Core is to develop an effective community of junior and senior investigators working
toward the common goal of improving treatment and outcomes of inflammatory rheumatic and MSK disease.
In addition, the Administrative Core provides scientific oversight of all aspects of the Methodology and
Bioinformatics Resource Cores. These objectives are accomplished through the following Specific Aims: Aim
1. To facilitate and supervise the scientific and administrative work of the Methodology and Bioinformatics
Resource Cores, so that the needs of the Research Community are met in an efficient and responsible
manner. Aim 2. To train and mentor the next generation of clinical researchers in rheumatology.
In sum, the VERITY Administrative Core will provide effective scientific and administrative oversight to
ensure optimal use of the Methodology and Bioinformatics Resource Core services. Moreover, the Enrichment
Program will attract, educate, and mentor the next generation of clinical researchers to enhance pediatric and
adult rheumatic and MSK disease research in the US.
抽象的
行政核心代表行政、培训、协调和监督部分
布莱根妇女医院 (BWH) 临床研究核心中心 (CCCR) BWH CCCR,
VERITY(使用生物信息学和高级分析学的风湿病学价值和证据),利用
BWH 和哈佛医学院 (HMS) 附属医院的资源为患者提供服务
由 NIAMS 使命定义的临床研究人员社区,在当地和全国范围内提供服务。
通过方法和生物信息学资源核心响应我们已确定的需求,以便更好地访问
以简化且易于访问的格式组织的完整的试验和生物信息学方法。
行政核心包含一个创新的丰富计划,用于培训和指导儿科和成人
当地和全国的风湿病和肌肉骨骼 (MSK) 临床研究人员。
该计划以儿科和成人培训项目主管的初步全国调查数据为基础
描述临床研究培训和持续研究指导的需求。
VERITY 管理核心是建立一个由初级和高级调查员组成的有效社区
朝着改善炎症性风湿病和 MSK 疾病的治疗和结果的共同目标。
此外,行政核心还对方法论的各个方面进行科学监督,并
生物信息学资源核心通过以下具体目标来实现: 目标
1. 促进和监督方法学和生物信息学的科学和行政工作
资源核心,以便以高效和负责任的方式满足研究界的需求
目标 2. 培训和指导下一代风湿病学临床研究人员。
总之,VERITY 管理核心将为以下组织提供有效的科学和行政监督:
确保方法学和生物信息学资源核心服务的最佳使用。
该计划将吸引、教育和指导下一代临床研究人员,以提高儿科和
美国成人风湿病和 MSK 疾病研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Hal Solomon其他文献
Daniel Hal Solomon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Hal Solomon', 18)}}的其他基金
Rheumatoid Arthritis and the Risk of Cardiovascular Disease: Biomarkers Risk Prediction and Underlying Mechanisms
类风湿关节炎和心血管疾病的风险:生物标志物风险预测和潜在机制
- 批准号:
10643971 - 财政年份:2022
- 资助金额:
$ 31.27万 - 项目类别:
Rheumatoid Arthritis and the Risk of Cardiovascular Disease: Biomarkers Risk Prediction and Underlying Mechanisms
类风湿关节炎和心血管疾病的风险:生物标志物风险预测和潜在机制
- 批准号:
10416473 - 财政年份:2022
- 资助金额:
$ 31.27万 - 项目类别:
VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics
VERITY:使用生物信息学和高级分析学的风湿病学价值和证据
- 批准号:
9413618 - 财政年份:2017
- 资助金额:
$ 31.27万 - 项目类别:
VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics
VERITY:使用生物信息学和高级分析学的风湿病学价值和证据
- 批准号:
9768189 - 财政年份:2017
- 资助金额:
$ 31.27万 - 项目类别:
VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics
VERITY:使用生物信息学和高级分析在风湿病学中的价值和证据
- 批准号:
10705645 - 财政年份:2017
- 资助金额:
$ 31.27万 - 项目类别:
VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics
VERITY:使用生物信息学和高级分析学的风湿病学价值和证据
- 批准号:
10251973 - 财政年份:2017
- 资助金额:
$ 31.27万 - 项目类别:
VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics
VERITY:使用生物信息学和高级分析学的风湿病学价值和证据
- 批准号:
10017653 - 财政年份:2017
- 资助金额:
$ 31.27万 - 项目类别:
Towards Evidence-Based Monitoring of Low Dose Methotrexate: CIRT Ancillary Study
实现低剂量甲氨蝶呤的循证监测:CIRT 辅助研究
- 批准号:
9272426 - 财政年份:2014
- 资助金额:
$ 31.27万 - 项目类别:
相似海外基金
Understanding how exocrine-derived signals promote beta cell growth
了解外分泌信号如何促进 β 细胞生长
- 批准号:
10750765 - 财政年份:2024
- 资助金额:
$ 31.27万 - 项目类别:
Social Vulnerability, Sleep, and Early Hypertension Risk in Younger Adults
年轻人的社会脆弱性、睡眠和早期高血压风险
- 批准号:
10643145 - 财政年份:2023
- 资助金额:
$ 31.27万 - 项目类别:
Sex, Physiological State, and Genetic Background Dependent Molecular Characterization of CircuitsGoverning Parental Behavior
控制父母行为的回路的性别、生理状态和遗传背景依赖性分子特征
- 批准号:
10661884 - 财政年份:2023
- 资助金额:
$ 31.27万 - 项目类别:
Characterizing the genetic etiology of delayed puberty with integrative genomic techniques
利用综合基因组技术表征青春期延迟的遗传病因
- 批准号:
10663605 - 财政年份:2023
- 资助金额:
$ 31.27万 - 项目类别:
Curing Through Collaboration: Utilizing Cooperative Groups in the Fight Against Chronic Lymphocytic Leukemia and B-cell Lymphomas
通过合作进行治愈:利用合作团体对抗慢性淋巴细胞白血病和 B 细胞淋巴瘤
- 批准号:
10566833 - 财政年份:2023
- 资助金额:
$ 31.27万 - 项目类别: